# Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light

> **NCT01256203** · PHASE2 · WITHDRAWN · sponsor: **Pinnacle Biologics Inc.**

## Conditions studied

- High-grade Dysplasia in Barrett Esophagus
- Non Small Cell Lung Cancer
- Esophageal Cancer

## Interventions

- **DRUG:** Solar Protection Formula SPF® 60
- **PROCEDURE:** Photobiological testing

## Key facts

- **NCT ID:** NCT01256203
- **Lead sponsor:** Pinnacle Biologics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-05
- **Primary completion:** 2013-12
- **Final completion:** 2014-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor cancelled the study
- **Last updated:** 2014-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01256203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01256203, "Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01256203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*